Application of Infrared Free-Electron Laser Irradiation of Protein Complexes Binding to Salen-Type Schiff Base Zn(II) Complexes Using Secondary Conformational Changes in the Proteins for the Treatment of Alzheimer’s Disease

Alzheimer’s disease causes the destruction of cranial nerve cells and is said to be caused by neuronal cell death due to the accumulation of amyloid-β protein. One method for the treatment of Alzheimer’s disease is to reduce the toxicity of the amyloid beta protein. Among the possibilities is to red...

Full description

Bibliographic Details
Main Authors: Hiroshi Takashima, Daisuke Nakane, Takashiro Akitsu
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Inorganics
Subjects:
Online Access:https://www.mdpi.com/2304-6740/12/2/50
_version_ 1797297944122097664
author Hiroshi Takashima
Daisuke Nakane
Takashiro Akitsu
author_facet Hiroshi Takashima
Daisuke Nakane
Takashiro Akitsu
author_sort Hiroshi Takashima
collection DOAJ
description Alzheimer’s disease causes the destruction of cranial nerve cells and is said to be caused by neuronal cell death due to the accumulation of amyloid-β protein. One method for the treatment of Alzheimer’s disease is to reduce the toxicity of the amyloid beta protein. Among the possibilities is to reduce toxicity by changing the secondary structure of the protein. In this study, the secondary structure of the protein was verified by binding a zinc complex to the protein and irradiating it with an infrared free-electron laser (IR-FEL). By binding Salen-Type zinc complexes to human serum albumin (HSA) and irradiating it with IR-FEL, structural changes were observed in the α-helix and β-sheet, the secondary structure of HSA. In addition to researching the possibility of binding zinc complexes to small proteins, docking simulations were examined. GOLD docking simulations showed that it is possible to bind zinc complexes to lysozyme (Lyz), a small protein. These results suggest that binding zinc complexes to amyloid-β and inducing a secondary conformational change through IR-FEL irradiation could be used for the treatment of Alzheimer’s disease by making the complexes lose their toxicity.
first_indexed 2024-03-07T22:27:39Z
format Article
id doaj.art-6af29f0dd0a14278b5dc9bd8fb55dd6e
institution Directory Open Access Journal
issn 2304-6740
language English
last_indexed 2024-03-07T22:27:39Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Inorganics
spelling doaj.art-6af29f0dd0a14278b5dc9bd8fb55dd6e2024-02-23T15:21:20ZengMDPI AGInorganics2304-67402024-02-011225010.3390/inorganics12020050Application of Infrared Free-Electron Laser Irradiation of Protein Complexes Binding to Salen-Type Schiff Base Zn(II) Complexes Using Secondary Conformational Changes in the Proteins for the Treatment of Alzheimer’s DiseaseHiroshi Takashima0Daisuke Nakane1Takashiro Akitsu2Department of Chemistry, Faculty of Science, Tokyo University of Science, 1-3 Kagurazaka, Tokyo 162-8601, JapanDepartment of Chemistry, Faculty of Science, Tokyo University of Science, 1-3 Kagurazaka, Tokyo 162-8601, JapanDepartment of Chemistry, Faculty of Science, Tokyo University of Science, 1-3 Kagurazaka, Tokyo 162-8601, JapanAlzheimer’s disease causes the destruction of cranial nerve cells and is said to be caused by neuronal cell death due to the accumulation of amyloid-β protein. One method for the treatment of Alzheimer’s disease is to reduce the toxicity of the amyloid beta protein. Among the possibilities is to reduce toxicity by changing the secondary structure of the protein. In this study, the secondary structure of the protein was verified by binding a zinc complex to the protein and irradiating it with an infrared free-electron laser (IR-FEL). By binding Salen-Type zinc complexes to human serum albumin (HSA) and irradiating it with IR-FEL, structural changes were observed in the α-helix and β-sheet, the secondary structure of HSA. In addition to researching the possibility of binding zinc complexes to small proteins, docking simulations were examined. GOLD docking simulations showed that it is possible to bind zinc complexes to lysozyme (Lyz), a small protein. These results suggest that binding zinc complexes to amyloid-β and inducing a secondary conformational change through IR-FEL irradiation could be used for the treatment of Alzheimer’s disease by making the complexes lose their toxicity.https://www.mdpi.com/2304-6740/12/2/50IR-FELcomplexamyloid-βHSAzincsecondary structure
spellingShingle Hiroshi Takashima
Daisuke Nakane
Takashiro Akitsu
Application of Infrared Free-Electron Laser Irradiation of Protein Complexes Binding to Salen-Type Schiff Base Zn(II) Complexes Using Secondary Conformational Changes in the Proteins for the Treatment of Alzheimer’s Disease
Inorganics
IR-FEL
complex
amyloid-β
HSA
zinc
secondary structure
title Application of Infrared Free-Electron Laser Irradiation of Protein Complexes Binding to Salen-Type Schiff Base Zn(II) Complexes Using Secondary Conformational Changes in the Proteins for the Treatment of Alzheimer’s Disease
title_full Application of Infrared Free-Electron Laser Irradiation of Protein Complexes Binding to Salen-Type Schiff Base Zn(II) Complexes Using Secondary Conformational Changes in the Proteins for the Treatment of Alzheimer’s Disease
title_fullStr Application of Infrared Free-Electron Laser Irradiation of Protein Complexes Binding to Salen-Type Schiff Base Zn(II) Complexes Using Secondary Conformational Changes in the Proteins for the Treatment of Alzheimer’s Disease
title_full_unstemmed Application of Infrared Free-Electron Laser Irradiation of Protein Complexes Binding to Salen-Type Schiff Base Zn(II) Complexes Using Secondary Conformational Changes in the Proteins for the Treatment of Alzheimer’s Disease
title_short Application of Infrared Free-Electron Laser Irradiation of Protein Complexes Binding to Salen-Type Schiff Base Zn(II) Complexes Using Secondary Conformational Changes in the Proteins for the Treatment of Alzheimer’s Disease
title_sort application of infrared free electron laser irradiation of protein complexes binding to salen type schiff base zn ii complexes using secondary conformational changes in the proteins for the treatment of alzheimer s disease
topic IR-FEL
complex
amyloid-β
HSA
zinc
secondary structure
url https://www.mdpi.com/2304-6740/12/2/50
work_keys_str_mv AT hiroshitakashima applicationofinfraredfreeelectronlaserirradiationofproteincomplexesbindingtosalentypeschiffbasezniicomplexesusingsecondaryconformationalchangesintheproteinsforthetreatmentofalzheimersdisease
AT daisukenakane applicationofinfraredfreeelectronlaserirradiationofproteincomplexesbindingtosalentypeschiffbasezniicomplexesusingsecondaryconformationalchangesintheproteinsforthetreatmentofalzheimersdisease
AT takashiroakitsu applicationofinfraredfreeelectronlaserirradiationofproteincomplexesbindingtosalentypeschiffbasezniicomplexesusingsecondaryconformationalchangesintheproteinsforthetreatmentofalzheimersdisease